Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER_GOV × Melanoma × FMT protocol × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Interventions

Interleukin-2 4 Nivolumab 3 Melphalan 3 pembrolizumab 2 tremelimumab 1 tislelizumab 1 fludarabine 1 encorafenib 1 binimetinib 1 apatinib 1 Tramadol 1 Surgical Procedures, Operative 1 Metastasectomy 1 Ipilimumab 1 Immunotherapy 1 Ibuprofen 1 FMT protocol 1 Cyclophosphamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03166397 2023-01-26

Adoptive Cell Therapy Following a Non-myeloablative, Lymphodepleting Induction Regimen in Metastatic Melanoma Patients

Sheba Medical Center

Phase 2 Recruiting

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡